Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,855,276
+$133,306 QoQ
Shares Held
50,123
-0.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#198
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST MANHATTAN CO. LLC. holds $503,568,677 across 13 Drug Manufacturers - General names. NVS ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
704,715 | $178,976,468 | |
| 2 | ABBV |
AbbVie Inc.
|
594,732 | $149,658,360 | |
| 3 | LLY |
ELI LILLY & Co
|
72,685 | $87,180,576 | |
| 4 | AMGN |
Amgen Inc
|
87,079 | $31,533,047 | |
| 5 | MRK |
Merck & Co., Inc.
|
158,760 | $20,400,660 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
70,366 | $8,890,040 | |
| 7 | NVS |
Novartis AG
This page
|
50,123 | $7,855,276 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
118,863 | $6,848,886 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,855,276 | 50,123 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,721,970 | 50,553 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,329,060 | 45,906 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,760,925 | 44,923 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,548,066 | 45,848 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,513,800 | 49,460 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,831,246 | 49,648 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,341,643 | 46,441 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,113,486 | 48,032 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,739,092 | 48,993 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,138,565 | 50,892 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,243,752 | 51,480 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,270,832 | 52,233 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,297,144 | 198,882 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,327,435 | 202,022 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,285,611 | 201,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,170,917 | 203,134 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,794,208 | 202,783 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $26,025,561 | 297,537 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $24,475,690 | 299,287 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $27,361,872 | 299,889 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $25,654,343 | 300,121 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $28,345,147 | 300,171 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,571,828 | 75,573 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,606,834 | 75,645 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,742,183 | 81,773 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||